A vaccine which would prevent and even reverse the early stages of Alzheimer's and dementia should be ready for human testing within the next two to three years. We talk to Maurice Curtis from the Neurological Foundation's Human Brain Bank.
Recent stories from Morning Report
Get the RNZ app
for easy access to all your favourite programmes
